StonvexLoading…
StonvexStonvexStonvexCore line items from ALSN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-08-03 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $1.54B | $1.41B | $3.01B | $2.27B | $1.58B |
Operating Income | Not available | $195.00M | $880.00M | $709.00M | $505.00M |
Net Income | Not available | $112.00M | $623.00M | $524.00M | $387.00M |
EPS (Diluted) | $2.58 | $1.33 | $7.33 | $6.16 | $4.50 |
Total Assets | Not available | $8.70B | $6.08B | $5.52B | $5.41B |
Total Liabilities | Not available | $6.80B | $4.21B | $3.68B | $3.66B |
Cash & Equivalents | Not available | $311.00M | $1.50B | $902.00M | $778.00M |
Free Cash Flow OCF − CapEx | Not available | $103.00M | $661.00M | $492.00M | $308.00M |
Shares Outstanding | Not available | 84.00M | 85.00M | 85.00M | 86.00M |